9-91723646-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004560.4(ROR2):​c.*16G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.705 in 1,611,668 control chromosomes in the GnomAD database, including 403,778 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 40802 hom., cov: 31)
Exomes 𝑓: 0.70 ( 362976 hom. )

Consequence

ROR2
NM_004560.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.29

Publications

15 publications found
Variant links:
Genes affected
ROR2 (HGNC:10257): (receptor tyrosine kinase like orphan receptor 2) The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development. Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]
ROR2 Gene-Disease associations (from GenCC):
  • brachydactyly type B1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive Robinow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 9-91723646-C-T is Benign according to our data. Variant chr9-91723646-C-T is described in ClinVar as Benign. ClinVar VariationId is 199097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.905 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ROR2NM_004560.4 linkc.*16G>A 3_prime_UTR_variant Exon 9 of 9 ENST00000375708.4 NP_004551.2 Q01974

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ROR2ENST00000375708.4 linkc.*16G>A 3_prime_UTR_variant Exon 9 of 9 1 NM_004560.4 ENSP00000364860.3 Q01974
ROR2ENST00000375715.5 linkc.1920+508G>A intron_variant Intron 9 of 12 1 ENSP00000364867.1 B1APY4
ROR2ENST00000550066.5 linkn.3316G>A non_coding_transcript_exon_variant Exon 11 of 11 2

Frequencies

GnomAD3 genomes
AF:
0.730
AC:
110898
AN:
151902
Hom.:
40747
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.759
Gnomad AMI
AF:
0.702
Gnomad AMR
AF:
0.775
Gnomad ASJ
AF:
0.629
Gnomad EAS
AF:
0.927
Gnomad SAS
AF:
0.623
Gnomad FIN
AF:
0.794
Gnomad MID
AF:
0.693
Gnomad NFE
AF:
0.691
Gnomad OTH
AF:
0.715
GnomAD2 exomes
AF:
0.735
AC:
182694
AN:
248436
AF XY:
0.723
show subpopulations
Gnomad AFR exome
AF:
0.766
Gnomad AMR exome
AF:
0.855
Gnomad ASJ exome
AF:
0.634
Gnomad EAS exome
AF:
0.926
Gnomad FIN exome
AF:
0.788
Gnomad NFE exome
AF:
0.692
Gnomad OTH exome
AF:
0.716
GnomAD4 exome
AF:
0.703
AC:
1025973
AN:
1459648
Hom.:
362976
Cov.:
66
AF XY:
0.700
AC XY:
507900
AN XY:
726090
show subpopulations
African (AFR)
AF:
0.769
AC:
25725
AN:
33470
American (AMR)
AF:
0.846
AC:
37788
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.637
AC:
16615
AN:
26066
East Asian (EAS)
AF:
0.946
AC:
37548
AN:
39698
South Asian (SAS)
AF:
0.630
AC:
54284
AN:
86142
European-Finnish (FIN)
AF:
0.776
AC:
40872
AN:
52644
Middle Eastern (MID)
AF:
0.669
AC:
3589
AN:
5366
European-Non Finnish (NFE)
AF:
0.690
AC:
767107
AN:
1111292
Other (OTH)
AF:
0.704
AC:
42445
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
16951
33902
50852
67803
84754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19652
39304
58956
78608
98260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.730
AC:
111012
AN:
152020
Hom.:
40802
Cov.:
31
AF XY:
0.736
AC XY:
54684
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.759
AC:
31472
AN:
41458
American (AMR)
AF:
0.775
AC:
11848
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.629
AC:
2183
AN:
3468
East Asian (EAS)
AF:
0.927
AC:
4763
AN:
5140
South Asian (SAS)
AF:
0.623
AC:
2996
AN:
4812
European-Finnish (FIN)
AF:
0.794
AC:
8417
AN:
10598
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.691
AC:
46982
AN:
67948
Other (OTH)
AF:
0.716
AC:
1513
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1494
2988
4482
5976
7470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.701
Hom.:
6919
Bravo
AF:
0.734
Asia WGS
AF:
0.768
AC:
2671
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 13, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive Robinow syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Brachydactyly type B1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.15
DANN
Benign
0.56
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230578; hg19: chr9-94485928; COSMIC: COSV65218526; API